TERESA CORRIGAN: Open Payments
NPI 1386841765 · MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 42 payments from 10 companies in 2025. Trend: 2023 $583 · 2024 $311 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $184 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Amgen Inc. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $62 |
| Janssen Biotech, Inc. | 3 | $61 |
| UCB, Inc. | 3 | $61 |
| Kerecis Limited | 3 | $43 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, Otezla, COSENTYX, ILUMYA, Bimzelx.
Industry payments across KS — which companies pay providers there.
